 | Up a level |
Lehrke, M; Konrad, A; Schachinger, V; Tillack, C; Seibold, F; Stark, R; Parhofer, KG; Broedl, UC (2007). CXCL 16 is a surrogate marker of inflammatory bowel disease. Scandinavian journal of gastroenterology, 43(3), pp. 283-288. London: Informa Healthcare 10.1080/00365520701679249
Broedl, UC; Schachinger, V; Lingenhel, A; Lehrke, M; Stark, R; Seibold, F; Goke, B; Kronenberg, F; Parhofer, KG; Konrad-Zerna, A (2006). Apolipoprotein A-IV is an independent predictor of disease activity in patients with inflammatory bowel disease. Inflammatory bowel diseases, 13(4), pp. 391-397. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20078
